Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis

This study has been completed.
Information provided by (Responsible Party):
Magdalena Madero, Instituto Nacional de Cardiologia Ignacio Chavez Identifier:
First received: March 17, 2009
Last updated: October 23, 2012
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)